Tetraphase Pharmaceuticals, Inc. EBITDA 2013-2020 | TTPH
Tetraphase Pharmaceuticals, Inc. ebitda from 2013 to 2020. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Tetraphase Pharmaceuticals, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2019 | $-67 |
| 2018 | $-73 |
| 2017 | $-115 |
| 2016 | $-78 |
| 2015 | $-83 |
| 2014 | $-65 |
| 2013 | $-28 |
| 2012 | $-13 |
| 2011 | $-21 |
| Tetraphase Pharmaceuticals, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2020-03-31 | $-12 |
| 2019-12-31 | $-11 |
| 2019-09-30 | $-14 |
| 2019-06-30 | $-22 |
| 2019-03-31 | $-19 |
| 2018-12-31 | $-21 |
| 2018-09-30 | $-20 |
| 2018-06-30 | $-10 |
| 2018-03-31 | $-22 |
| 2017-12-31 | $-24 |
| 2017-09-30 | $-30 |
| 2017-06-30 | $-32 |
| 2017-03-31 | $-30 |
| 2016-12-31 | $-22 |
| 2016-09-30 | $-21 |
| 2016-06-30 | $-17 |
| 2016-03-31 | $-17 |
| 2015-12-31 | $-18 |
| 2015-09-30 | $-18 |
| 2015-06-30 | $-26 |
| 2015-03-31 | $-21 |
| 2014-12-31 | $-20 |
| 2014-09-30 | $-14 |
| 2014-06-30 | $-18 |
| 2014-03-31 | $-13 |
| 2013-12-31 | $-11 |
| 2013-09-30 | $-10 |
| 2013-06-30 | $-5 |
| 2013-03-31 | $-3 |
| 2012-12-31 | $-3 |
| 2012-09-30 | $-3 |
| 2012-06-30 | $-4 |
| 2012-03-31 | $-4 |
